Post regarding COVID19
In a completely virtual and innovative setting, Puerto Rico celebrated its “Clinical and Translational Research Week in Puerto Rico (CTRWPR) from May 3-7, 2021. This year the overarching topic was: The Multidimensional Impact of COVID-19. The organization and celebration of this main activity, for the development of clinical and translational research in…
March and April 2021 proved to be very busy with the submission of several NIH supplements, each of them related to the SARS-CoV-2, the virus which causes COVID-19. We highlight here four of these applications. If awarded, these studies/projects will be supplements to our Alliance CTR “parent grant” U54GM133807 The first submission, titled “SARS-CoV-2 genomic…
During public health emergencies like COVID-19, science — and the process of turning observations into new therapies — must be translated faster than ever. Vast amounts of clinical data are being generated that could be used to advance research efforts focused on COVID-19. These datasets often become too large to share and the networks for…
By: Nilda González, MS, MT Since the first months of the COVID-19 pandemic, the need for testing to identify possible infected patients was a health issue and priority globally. Puerto Rico was not an exception to this reality. As healthcare professionals, there is a commitment to be part of any initiative to promote and preserve…
PREPCOVI (PUERTO RICO-EVALUACION EPIDEMIOLOGICA Y PREVENCION PARA COVID-19 E INFLUENZA) PREPCOVI es una colaboración entre la Universidad de Puerto Rico, el Departamento de Salud y empresas de telecomunicaciones para entender el COVID-19 e Influenza en Puerto Rico. PREPCOVI está reclutando aleatoriamente personas de 21 años o más en todo Puerto Rico y los participantes recibirán…
Following the institutional and government directives for ensuring the safety of participants, investigators and personnel, we are following safety precautions for entering the Alliance facilities in the Medical Sciences Campus: